Obiettivo
Second-generation antipsychotics are increasingly being prescribed to children and adolescents. Their use, however, is mostly off-label, and adequate and sufficient data about efficacy and particular safety are lacking. This proposal focuses on two indications, the use of risperidone in children and adolescents with conduct disorder who are not mentally retarded, and the use of risperidone in adolescents with schizophrenia. The objectives are to 1) perform a series of clinical studies that will provide sufficient information for a Paediatric Use Marketing Authorisation to be obtained for these indications; 2) address scientific questions about the moderating and/or mediating factors of the efficacy and safety of risperidone in children and adolescents, and 3) disseminate the knowledge acquired by the proposed studies to medical and mental health professionals, to patients and their families and society in general.
Campo scientifico
Argomento(i)
Invito a presentare proposte
FP7-HEALTH-2009-single-stage
Vedi altri progetti per questo bando
Meccanismo di finanziamento
CP-FP - Small or medium-scale focused research projectCoordinatore
6525 XZ Nijmegen
Paesi Bassi
Mostra sulla mappa
Partecipanti (20)
9713 GZ Groningen
Mostra sulla mappa
68159 Mannheim
Mostra sulla mappa
WC1E 6BT London
Mostra sulla mappa
DD1 4HN Dundee
Mostra sulla mappa
WC1N 1AX LONDON
Mostra sulla mappa
75012 Paris
Mostra sulla mappa
28046 MADRID
Mostra sulla mappa
08036 Barcelona
Mostra sulla mappa
09124 Cagliari
Mostra sulla mappa
3000 Leuven
Mostra sulla mappa
56118 Pisa
Mostra sulla mappa
00165 Roma
Mostra sulla mappa
75654 Paris
Mostra sulla mappa
89081 Ulm
Mostra sulla mappa
LL139UF WREXHAM
Mostra sulla mappa
28037 MADRID
Mostra sulla mappa
82140 Olching
Mostra sulla mappa
5611 GZ Eindhoven
Mostra sulla mappa
KT11 3BN STOKE D ABERNON
Mostra sulla mappa
00197 Rome
Mostra sulla mappa